| ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA |
| A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19 |
| A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells |
| A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review |
| A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals |
| Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning |
| Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines |
| Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia |
| Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines |
| Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit? |
| An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies |
| Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches |
| Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination |
| Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections |
| Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose |
| Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine in the United States |
| BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting |
| Cardiac Adverse Reactions With COVID-19 Vaccinations |
| Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report |
| Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents |
| CDC Finally Released Its VAERS Safety Monitoring Analyses for COVID Vaccines via FOIA |
| CDC REMOVES Their Claim That mRNA & Spike Protein "Do Not Last Long In The Body” |
| Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis |
| Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis |
| Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study |
| Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines |
| Commentary from Dr. David Bauer of the Francis Crick Institute |
| Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants |
| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence |
| Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures |
| Correspondence: Myocarditis after Covid-19 mRNA Vaccination |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1 |
| COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 |
| COVID-19 mRNA Pfizer- BioNTech vaccine analysis print |
| COVID-19 RNA Based Vaccines and the Risk of Prion Disease |
| COVID-19 Vaccination-Associated Myocarditis: A Literature Review |
| COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device |
| COVID-19 Vaccine Lots |
| COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis |
| COVID-19 Vaccine: Critical Questions with Complicated Answers |
| Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds |
| Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine - Part 1 |
| Curing the pandemic of misinformation on COVID-19 mRNA vaccines through real evidence-based medicine - Part 2 |
| Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches |
| Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study |
| DEL BIGTREE SPEAKS TO 3 HEALTHCARE WORKERS INJURED BY THE VACCINE |
| Delayed Induction of Noninflammatory SARS-CoV-2 Spike-Specific IgG4 Antibodies Detected 1 Year After BNT162b2 Vaccination in Children |
| Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms |
| Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation |
| Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease |
